Crypto

CUBE3.AI Unveils AI-Driven Technology to Detect and Block Rising Tide of New Scams and Fraud

Palo Alto, California, United States, September 5th, 2024, Chainwire

AI-driven platform detects fraud at its earliest stages, preventing billions in potential crypto losses

As scams grow more sophisticated and increasingly target crypto for laundering billions in losses, CUBE3.AI is pioneering a new era in fraud prevention. Today, the company announced major enhancements to its platform that bridge the gap between Web2 and Web3, enabling real-time risk assessment and the proactive blocking of scams like pig butchering, ransomware, sextortion, and others.

In 2023, investment scams alone led to more than $4.5 billion in losses, with 86% linked to cryptocurrency. A substantial portion of these scams originate in Web2—through social media interactions, fraudulent websites, or other online channels—before transitioning into crypto where recovering stolen assets becomes nearly impossible. While the industry has traditionally focused on either Web2 or Web3, CUBE3.AI leverages unique expertise and proprietary AI technology that seamlessly integrates both realms, enabling the detection and prevention of fraud across the entire digital landscape. This approach addresses a critical gap by offering a holistic view of fraud patterns across both Web2 and Web3, enabling early detection, thorough risk assessment, and timely intervention.

“The most damaging scams often involve complex journeys that span both traditional and crypto spaces. We’ve built a solution that looks at the full picture, from initial contact in Web2 all the way to final transactions in Web3,” said Einaras Gravrock, CEO of CUBE3.AI. “Real-time fraud prevention is a complex challenge that requires expertise in both realms, along with advanced technology capable of interpreting diverse data and understanding context. Our platform is more than just technology—it’s about restoring trust. Whether it’s protecting businesses from dirty money or safeguarding people from devastating losses, this solution marks a significant step forward in the fight against digital fraud.”

CUBE3.AI’s enhanced platform integrates data from social media, online platforms, and dark web sources, combining it with real-time Web3 transaction monitoring. Proprietary AI models trained to interpret the context of this data generate a comprehensive risk score, empowering businesses to act swiftly before scams escalate. By offering seamless visibility into both Web2 and Web3 activities, CUBE3.AI allows organizations to preemptively block threats that would otherwise go unnoticed until it’s too late.

“As criminals increasingly rely on AI to scale their attacks, our response has to be just as sophisticated. Our AI-powered tools connect the dots between Web2 and Web3, giving us a unique edge in identifying threats before they escalate,” said Chris Griffiths, CTO of CUBE3.AI. “By offering this level of visibility and speed, we empower businesses to make informed decisions and protect their users in real time.”

These new capabilities provide exchanges, financial institutions, and service providers with the early detection and risk management they need to avoid facilitating fraud, protect user trust, and minimize financial losses. By offering a solution that integrates data from both Web2 and Web3, CUBE3.AI sets a new standard in fraud prevention, helping businesses stay ahead of rapidly evolving threats.

About CUBE3.AI

CUBE3.AI is an innovative platform dedicated to real-time fraud and crypto crime prevention. Utilizing proprietary artificial intelligence models, CUBE3.AI protects digital assets and transactions from fraud, cyber exploits, hacks, scams, and compliance risks, empowering businesses to protect their assets, reduce chargebacks, and minimize financial losses. Our technology not only responds to incidents but also anticipates and prevents them before they occur, safeguarding businesses and individuals from the risks associated with crypto transactions.

The company was founded by a team of machine learning researchers, fraud prevention specialists, white hats and blockchain engineers, and is backed by leading investors – including Blockchange Ventures, Dispersion Capital, Symbolic Capital, Hypersphere Ventures, ICLUB and TA Ventures. Users can learn more at www.CUBE3.AI and join CUBE3.AI on LinkedInTwitter and Telegram.

Contact

Head of Marketing
Rasa Petuch
CUBE3.AI
rasap@cube3.ai

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

2024-09-17T13:00:00Z

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RENB) - PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which RenovaroCube is based.

Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

RenovaroCube's AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

The initial aim is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

In their analysis, PersonalAIze noted the platform's focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

Based on these findings, PersonalAIze is eager to collaborate further with RenovaroCube to enhance and commercialize the platform.

PersonalAIze aims to contribute in several key areas:

  • Advancing AI models by leveraging the latest state-of-the-art techniques.
  • Supporting the professional growth of the software team.
  • Enhancing the explainability of AI models, engaging clinicians in model development.
  • Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

This partnership could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

About Renovaro
Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

About PersonalAIze
PersonalAIze focusses on building solutions that improve healthcare by leveraging state-of-the-art AI techniques. It has been founded by four experienced professors bringing together decades of research experience in AI and healthcare with the aim to bring the latest scientific AI developments into healthcare practice faster. PersonalAIze does this through both consultancy and product development and targets clinical decision making systems as well as improvement of health care operations such as capacity planning.

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For media inquiries, please contact: karen@renovarocube.com

Source: Renovaro Inc.


GlobeNewsWire News

Recent Comments